The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Trevor Baglin, Andreas Hillarp, Armando Tripodi et al. · Journal of Thrombosis and Haemostasis · 2013 · 255 citations

Medicine, Hematology, Pharmacology +16

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology

Trevor Baglin, David Keeling, Steve Kitchen · British Journal of Haematology · 2012 · 165 citations · Full text

Medicine, Hematology, Pharmacology +17

New oral anticoagulants: a practical guide on prescription, laboratory testing and peri‐procedural/bleeding management

Huy Tran, Joanne Joseph, Laura Young et al. · Internal Medicine Journal · 2014 · 151 citations · Full text

Medicine, Perioperative Medicine, Pharmacology +17

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Anne Tamigniau, Bernard Châtelain, C Chatelain et al. · Thrombosis and Haemostasis · 2013 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Andreas Hillarp, Kerstin M. Gustafsson, Lars Faxälv et al. · Journal of Thrombosis and Haemostasis · 2014 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12